Cargando…
Comment on: “Myostatin inhibition in combination with antisense oligonucleotide therapy improves outcomes in spinal muscular atrophy” by Zhou et al.
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7567159/ https://www.ncbi.nlm.nih.gov/pubmed/32716121 http://dx.doi.org/10.1002/jcsm.12607 |
| _version_ | 1783596267429953536 |
|---|---|
| author | Chen, Tai‐Heng |
| author_facet | Chen, Tai‐Heng |
| author_sort | Chen, Tai‐Heng |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7567159 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | John Wiley and Sons Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-75671592020-10-21 Comment on: “Myostatin inhibition in combination with antisense oligonucleotide therapy improves outcomes in spinal muscular atrophy” by Zhou et al. Chen, Tai‐Heng J Cachexia Sarcopenia Muscle Letters to the Editor John Wiley and Sons Inc. 2020-07-27 2020-10 /pmc/articles/PMC7567159/ /pubmed/32716121 http://dx.doi.org/10.1002/jcsm.12607 Text en © 2020 The Authors. Journal of Cachexia, Sarcopenia and Muscle published by John Wiley & Sons Ltd on behalf of Society on Sarcopenia, Cachexia and Wasting Disorders This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
| spellingShingle | Letters to the Editor Chen, Tai‐Heng Comment on: “Myostatin inhibition in combination with antisense oligonucleotide therapy improves outcomes in spinal muscular atrophy” by Zhou et al. |
| title | Comment on: “Myostatin inhibition in combination with antisense oligonucleotide therapy improves outcomes in spinal muscular atrophy” by Zhou et al. |
| title_full | Comment on: “Myostatin inhibition in combination with antisense oligonucleotide therapy improves outcomes in spinal muscular atrophy” by Zhou et al. |
| title_fullStr | Comment on: “Myostatin inhibition in combination with antisense oligonucleotide therapy improves outcomes in spinal muscular atrophy” by Zhou et al. |
| title_full_unstemmed | Comment on: “Myostatin inhibition in combination with antisense oligonucleotide therapy improves outcomes in spinal muscular atrophy” by Zhou et al. |
| title_short | Comment on: “Myostatin inhibition in combination with antisense oligonucleotide therapy improves outcomes in spinal muscular atrophy” by Zhou et al. |
| title_sort | comment on: “myostatin inhibition in combination with antisense oligonucleotide therapy improves outcomes in spinal muscular atrophy” by zhou et al. |
| topic | Letters to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7567159/ https://www.ncbi.nlm.nih.gov/pubmed/32716121 http://dx.doi.org/10.1002/jcsm.12607 |
| work_keys_str_mv | AT chentaiheng commentonmyostatininhibitionincombinationwithantisenseoligonucleotidetherapyimprovesoutcomesinspinalmuscularatrophybyzhouetal |